Cite
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
MLA
Lam, Phillip H., et al. “Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.” American Journal of Medicine, vol. 131, no. 12, Dec. 2018, pp. 1473–81. EBSCOhost, https://doi.org/10.1016/j.amjmed.2018.07.008.
APA
Lam, P. H., Gupta, N., Dooley, D. J., Singh, S., Deedwania, P., Zile, M. R., Bhatt, D. L., Morgan, C. J., Pitt, B., Fonarow, G. C., & Ahmed, A. (2018). Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate. American Journal of Medicine, 131(12), 1473–1481. https://doi.org/10.1016/j.amjmed.2018.07.008
Chicago
Lam, Phillip H., Neha Gupta, Daniel J. Dooley, Steven Singh, Prakash Deedwania, Michael R. Zile, Deepak L. Bhatt, et al. 2018. “Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.” American Journal of Medicine 131 (12): 1473–81. doi:10.1016/j.amjmed.2018.07.008.